HomeCancerLung

Lung

Lung

Roche’s Tecentriq retries for insurance coverage protection as adjuvant remedy after lung most cancers surgical procedure < Pharma < Article

Editor -
Roche Korea has renewed its bid for medical insurance protection of its anti-PD-L1 immuno-oncology drug Tecentriq (atezolizumab) as an adjuvant remedy after surgical...
Lung

Habitat radiomics and deep studying fusion nomogram to foretell EGFR mutation standing in stage I non-small cell lung most cancers: a multicenter examine

Editor -
Research designOur examine introduces 4 radiomic fashions encompassing intratumoral, peritumoral, and habitat area radiomics, together with deep studying fashions. The workflow of the...
Lung

First Affected person Dosed with PD-L1 Nanobody in Section 1 Therapeutic Non-Small Cell Lung Most cancers Trial

Editor -
At this yr’s Collision occasion, held in Toronto from June 18 to twenty, Wesley Chan, co-founder and managing companion at enterprise capital agency...
Lung

White Ribbon Venture works with outreach arm of KU Most cancers Heart to extend lung most cancers screenings in Kansas

Editor -
There's a false assumption that folks identified with lung most cancers are by some means liable for their illness. Not like different types...
Lung

Lung Most cancers: Lung Most cancers in Non-Smoking Indians: Early Onset In comparison with Westerners | Mumbai Information

Editor -
Mumbai: A lung most cancers affected person in India is more likely to be 10 years youthful than a affected person within the...
1...535455...82Page 54 of 82

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.